Form 4: Gossamer Bio Executive Receives Stock Grant
Insider Transaction (Form 4)
Caryn Peterson, Chief Development Officer of Gossamer Bio, Inc., received 5,800,051 shares of common stock on August 24, 2026.
Summary
- Grant/award: acquired 5,800,051 Stock Option (Right to Buy) on August 24, 2026; holds 5,800,051 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Caryn Peterson — Officer (Chief Development Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-24 | Grant/award | Stock Option (Right to Buy) | 5,800,051 | — | — | 5,800,051 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-24 | Grant/award (5,800,051 shares) |
Keywords
insider transaction, Form 4, GOSS, Gossamer Bio, Inc., neutral, Caryn Peterson
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.